Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 10

1201P - Novel deep learning model and validation of whole slide images in lung cancer diagnosis

Date

14 Sep 2024

Session

Poster session 10

Presenters

Alhassan Ahmed

Citation

Annals of Oncology (2024) 35 (suppl_2): S762-S774. 10.1016/annonc/annonc1599

Authors

A.A. Ahmed1, M. Fawi2, A. Brychcy3, M. Abouzid4, M. Witt5, E. Kaczmarek1

Author affiliations

  • 1 Bioinformatics And Computational Biology, PUMS - Poznan University of Medical Sciences, 61-701 - Poznan/PL
  • 2 Data Science, Spider Silk Security DMCC, Dubai 282945, United Arab Emirates, 282945 - Dubai/AE
  • 3 Department Of Clinical Patomorphology, DeparHeliodor Swiecicki Clinical Hospital of the Poznan University of Medical Sciences, 61-806 - Poznań/PL
  • 4 Department Of Physical Pharmacy And Pharmacokinetics, PUMS - Poznan University of Medical Sciences, 61-701 - Poznan/PL
  • 5 Department Of Anatomy, PUMS - Poznan University of Medical Sciences, 61-701 - Poznan/PL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1201P

Background

Lung cancer is the leading cause of cancer-related deaths worldwide and the second cause of death in Poland. Two of the crucial factors contributing to these fatalities are delayed diagnosis and suboptimal prognosis. The rapid advancement of deep learning (DL) approaches provides a significant opportunity for medical imaging techniques to play a crucial role in the early diagnosis of lung tumors and the following stages of treatment. This study presents a DL-based model for efficient lung cancer detection using Whole Slide Images WSIs and validated by Polish active pathologists in order to support them on a daily basis.

Methods

Our methodology combines convolutional neural networks (CNNs) and separable CNNs with residual blocks, thereby improving classification performance. Our model improves accuracy (96% to 98%) and robustness in distinguishing between cancerous and non-cancerous lung cell images in less than 10 seconds.

Results

The model's overall performance surpassed that of active pathologists, with an accuracy of 100% vs. 79%. There was a significant linear correlation between pathologists' accuracy and years of experience (r Pearson = 0.71, 95% CI 0.14 to 0.93, p = 0.022).

Conclusions

We conclude that this model enhances the accuracy of cancer detection and the model outperformed results reported by active pathologists, suggesting that an AI algorithm assisted by pathologists can enhance diagnostic skills and reduce the lead time in the diagnosis process.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Poznan University of Medical Sciences.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.